LSD1 as a Biomarker and the Outcome of Its Inhibitors in the Clinical Trial: The Therapy Opportunity in Tumor

Tumors are the foremost cause of death worldwide. As a result of that, there has been a significant enhancement in the investigation, treatment methods, and good maintenance practices on cancer. However, the sensitivity and specificity of a lot of tumor biomarkers are not adequate. Hence, it is of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Agboyibor, Clement, Dong, Jianshu, Effah, Clement Yaw, Drokow, Emmanuel Kwateng, Pervaiz, Waqar, Liu, Hong-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018836/
https://www.ncbi.nlm.nih.gov/pubmed/33833800
http://dx.doi.org/10.1155/2021/5512524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018836/
https://www.ncbi.nlm.nih.gov/pubmed/33833800
http://dx.doi.org/10.1155/2021/5512524

Ejemplares similares